BioCentury
ARTICLE | Company News

CeNeS terminates Bioglan deals

April 2, 2002 8:00 AM UTC

CeNeS (LSE:CEN) said it had agreed with the administrators of Bioglan (LSE:BGP) to terminate a 2000 distribution and marketing deal for CEN's Moraxen morphine formulation to treat cancer pain and a se...